Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 4Pancreatic Intraductal Neoplasms 2

Interventions

tocotrienol, delta 2Paclitaxel 2dachengqi decoction 1Tomography, Optical Coherence 1Therapeutic Irrigation 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sulindac 1Secretin 1Saline Solution 1Pancreatectomy 1Octreotide 1Liquid Biopsy 1Hydrocortisone 1Ferrosoferric Oxide 1Ethanol 1Endosonography 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Pancreatic Intraductal Neoplasms × tocotrienol, delta × Clear all
NCT06519097 2025-11-13

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
4 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00985777 2016-03-01

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
26 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡